Home/Kailos Genetics/Ron McGlennen, M.D.
RM

Ron McGlennen, M.D.

Medical Director

Kailos Genetics

Therapeutic Areas

Kailos Genetics Pipeline

DrugIndicationPhase
Expedio™ Hereditary Cancer Risk TestingHereditary Cancer RiskCommercial
Inspexion™ Pharmacogenomic TestingDrug Response & MetabolismCommercial
Kailos Complete™/Flex™ Reagent ProgramsResearch Use (Hereditary Cancer/Pharmacogenomics)Commercial